» Articles » PMID: 20012079

Serum Protein Profiling of Smear-positive and Smear-negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2009 Dec 17
PMID 20012079
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The focus of this study was to detect novel sera biomarkers for smear-positive and smear-negative pulmonary tuberculosis and to establish respective diagnostic models using the surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) technique. A total of 155 sera samples from smear-positive pulmonary tuberculosis (SPPTB) and smear-negative pulmonary tuberculosis (SNPTB) patients and non-tuberculosis (non-TB) controls were analyzed with SELDI-TOF MS. The study was divided into a preliminary training set and a blinded testing set. A classification tree of spectra derived from 31 SPPTB patients, 22 SNPTB patients, and 42 non-TB controls were used to develop an optimal classification tree that discriminated them respectively in the training set. Then, the validity of the classification tree was challenged with another independent blinded testing set, which included 20 SPPTB patients, 14 SNPTB patients, and 26 non-TB controls. SNPTB patients and non-TB controls also were analyzed alone using the same method. The optimal decision tree model with a panel of nine biomarkers with mass:charge ratios (m/z) of 4821.45, 3443.22, 9284.93, 4473.86, 4702.84, 3443.22, 5343.26, 3398.27, and 3193.61 determined in the training set could detect 93.55%, 95.46%, and 88.09% accuracy for classifying SPPTB patients, SNPTB patients, and non-TB controls specimens, respectively. Validation of an independent, blinded testing set gave an accuracy of 80.77% for controls, 75.00% for SPPTB, and 71.43% for SNPTB samples using the same classification tree. With the peaks displaying differences between SNPTB patients and non-TB controls, a simplified dendrogram (m/z 4821.45, 4792.74) demonstrated classification efficacy of 85.94% (sensitivity 86.36% and specificity 85.71%) for distinguishing SNPTB patients from non-TB controls. The independent blinded testing set containing 14 SNPTB patients and 26 non-TB controls gained an accuracy of 81.59% (sensitivity 78.57% and specificity 84.62%) for diagnosing SNPTB. Special proteins/peptides may change in SPPTB and SNPTB patients and those changes may be used to distinguish them with the proper discriminant analytical method and to pursue and identify some involved proteins underlying the biological process of tuberculosis.

Citing Articles

Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism.

Ju Y, Jin C, Chen S, Wang J, Li C, Wang X Front Cell Infect Microbiol. 2023; 13:1240516.

PMID: 37908762 PMC: 10613889. DOI: 10.3389/fcimb.2023.1240516.


Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa.

Morris T, Hoggart C, Chegou N, Kidd M, Oni T, Goliath R Front Immunol. 2021; 12:639174.

PMID: 33717190 PMC: 7947659. DOI: 10.3389/fimmu.2021.639174.


Tuberculosis Biomarkers: From Diagnosis to Protection.

Goletti D, Petruccioli E, Joosten S, Ottenhoff T Infect Dis Rep. 2016; 8(2):6568.

PMID: 27403267 PMC: 4927936. DOI: 10.4081/idr.2016.6568.


Diagnostic 'omics' for active tuberculosis.

Haas C, Roe J, Pollara G, Mehta M, Noursadeghi M BMC Med. 2016; 14:37.

PMID: 27005907 PMC: 4804573. DOI: 10.1186/s12916-016-0583-9.


Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis.

Rukmangadachar L, Makharia G, Mishra A, Das P, Hariprasad G, Srinivasan A Sci Rep. 2016; 6:23162.

PMID: 26988818 PMC: 4796817. DOI: 10.1038/srep23162.


References
1.
Abebe F, Holm-Hansen C, Wiker H, Bjune G . Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol. 2007; 66(2-3):176-91. DOI: 10.1111/j.1365-3083.2007.01978.x. View

2.
Zhang M, Lin Y, Iyer D, Gong J, Abrams J, Barnes P . T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun. 1995; 63(8):3231-4. PMC: 173444. DOI: 10.1128/iai.63.8.3231-3234.1995. View

3.
Papadopoulos M, Abel P, Agranoff D, Stich A, Tarelli E, Bell B . A novel and accurate diagnostic test for human African trypanosomiasis. Lancet. 2004; 363(9418):1358-63. DOI: 10.1016/S0140-6736(04)16046-7. View

4.
Imaz M, Schmelling M, Kaempfer S, Spallek R, Singh M . Serodiagnosis of tuberculosis: specific detection of free and complex-dissociated antibodies anti-mycobacterium tuberculosis recombinant antigens. Braz J Infect Dis. 2008; 12(3):234-44. DOI: 10.1590/s1413-86702008000300014. View

5.
Demissie A, Wassie L, Abebe M, Aseffa A, Rook G, Zumla A . The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect Immun. 2006; 74(5):2817-22. PMC: 1459691. DOI: 10.1128/IAI.74.5.2817-2822.2006. View